Game-Changing Alliance: Adia Labs and Axia

Core Insights - Adia Nutrition Inc. has formed a strategic partnership with AxiaMD to enhance the delivery of regenerative therapies to chiropractic clinics across the United States under full physician oversight [1][2][3] Partnership Details - AxiaMD's network will provide Adia Labs' regenerative products to clients, while Adia Nutrition's clinics will benefit from AxiaMD's compliance and oversight services, ensuring operations are fully compliant across all 50 states [2][3] - This collaboration allows chiropractic clinics to perform advanced regenerative procedures with regulatory compliance, creating a scalable national platform for transformative therapies [3][4] Financial Performance - Adia Nutrition reported over 200% revenue growth in Q3 2025, indicating strong momentum leading to its OTCQB uplisting and potential Nasdaq eligibility [4] Product Offerings - Adia Labs specializes in FDA-compliant stem cell products, including AdiaVita and AdiaLink, and is expanding its offerings to include insurance-billable wound care products [5][7] - Adia Med clinics provide specialized regenerative treatments such as stem cell therapies, platelet-rich plasma (PRP), and advanced treatments like therapeutic plasma exchange (TPE) [5] Revenue Generation - The company generates revenue through service fees, product sales, equity stakes, and billing insurance for healthcare treatments, while also investing in aligned businesses like Cement Factory LLC [8]